000 01625 a2200445 4500
005 20250514060204.0
264 0 _c20030805
008 200308s 0 0 eng d
022 _a1015-2008
024 7 _a10.1159/000068151
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmidt, Carsten
245 0 0 _aInterleukin-12 antagonists as new therapeutic agents in inflammatory bowel disease.
_h[electronic resource]
260 _bPathobiology : journal of immunopathology, molecular and cellular biology
_c
300 _a177-83 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAntibodies, Blocking
_xtherapeutic use
650 0 4 _aColitis, Ulcerative
_ximmunology
650 0 4 _aCrohn Disease
_ximmunology
650 0 4 _aDimerization
650 0 4 _aDisease Models, Animal
650 0 4 _aHumans
650 0 4 _aImmunotherapy
650 0 4 _aImmunotoxins
_xtherapeutic use
650 0 4 _aInterleukin-12
_xantagonists & inhibitors
650 0 4 _aInterleukin-12 Subunit p40
650 0 4 _aMacrophage-1 Antigen
_ximmunology
650 0 4 _aMice
650 0 4 _aProtein Subunits
_xtherapeutic use
650 0 4 _aRecombinant Fusion Proteins
_xtherapeutic use
650 0 4 _aTh1 Cells
_xdrug effects
700 1 _aMarth, Thomas
700 1 _aWittig, Bianca M
700 1 _aHombach, Andreas
700 1 _aAbken, Hinrich
700 1 _aStallmach, Andreas
773 0 _tPathobiology : journal of immunopathology, molecular and cellular biology
_gvol. 70
_gno. 3
_gp. 177-83
856 4 0 _uhttps://doi.org/10.1159/000068151
_zAvailable from publisher's website
999 _c12369518
_d12369518